Home > Back to Publisher > Report Information

The Elder Care Market: Products and Services

BCC Research
June 1, 2009
213 Pages - SKU: WA2292435

Abstract Table of Contents Related Reports

Countries covered: United States

REPORT HIGHTLIGHTS

The U.S. eldercare market was worth $279.2 billion in 2008 and an estimated $316.9 billion in 2009. This should reach $447.4 billion in 2014, for a compound annual growth rate (CAGR) of 7.1%.
The healthcare segment has the largest share of the market, worth $146.4 billion in 2008 and an estimated $172.2 billion in 2009. This should increase at a CAGR of 9.1% to reach $266.8 billion in 2014.
The housing segment has the second-largest market share, generating $127.4 billion in 2008. This segment is expected to reach $138.7 billion in 2009 and $171.5 billion in 2014, for a CAGR of 4.3%.

CHAPTER ONE: INTRODUCTION: STUDY GOAL AND OBJECTIVES; REASONS FOR DOING THE STUDY; INTENDED AUDIENCE; SCOPE OF REPORT; METHODOLOGY; INFORMATION SOURCES; AUTHOR’S CREDENTIALS; RELATED BCC PUBLICATIONS; BCC ONLINE SERVICES; DISCLAIMER
CHAPTER TWO: SUMMARY: DECISIVE CHANGES IN LIVES; WHAT DOES THE FUTURE HOLD?; PROJECTIONS FOR FUTURE NEEDS; SOURCE: BCC RESEARCH
CHAPTER 3: DEMOGRAPHICS OF THE ELDERCARE MARKET: DEFINITIONS; GLOBAL SOCIAL ENVIRONMENT; INTERGENERATIONAL LIVING ISSUES IN DEVELOPING COUNTRIES; INTERGENERATIONAL-LIVING ISSUES IN DEVELOPED COUNTRIES; GLOBAL ECONOMIC ENVIRONMENT; DEMOGRAPHICS IN THE UNITED STATES; SHIFTING DEMOGRAPHICS IN THE U.S; RACIAL AND ETHNIC CHANGES; HEALTH OF THE ELDERLY IN THE U.S.; DISCREPANCIES IN MINORITY HEALTH STATUS; LIVING WITH LIMITATIONS; LONG-TERM CARE SPENDING; U.S. HEALTH TRENDS; MORTALITY AND U.S. SENIORS; INDIVIDUAL BEHAVIORS AND MORTALITY; ECONOMIC TRENDS FOR U.S. SENIORS; HOUSING TRENDS FOR U.S. SENIORS; Housing Options; LIFESTYLE TRENDS FOR SENIORS IN THE U.S.; INTERNATIONAL DEMOGRAPHICS; HEALTH OF THE ELDERLY AROUND THE GLOBE; ECONOMIC TRENDS OUTSIDE THE U.S.; HOUSING TRENDS OUTSIDE THE U.S; GLOBAL LIFESTYLE TRENDS OF THE ELDERLY; CHAPTER FOUR: OVERVIEW OF HEALTHCARE FUNDING POSSIBILITIES; U. S. AND INTERNATIONAL HEALTHCARE COSTS; TABLE 3 COMPARISON OF ESTIMATED GOVERNMENT HEALTHCARE SPENDING AS PERCENT OF GDP, 2007 (%/$ MILLIONS)); U.S. RETIREMENT FUNDING; Individual Retirement Savings; Social Security; Social Security Beneficiaries; Social Security Solvency; Company-sponsored Pension Plans; GLOBAL RETIREMENT FUNDING; Individual Retirement Savings; Social Security; TYPES OF HEALTHCARE FUNDING IN THE U.S; Private Insurance; Long Term Care Insurance; Medicare; Medicare Part A; Medicare Part B; Medicare Part C; Medicare Part D; Medicaid; Medicaid Spending and Community-based Services; Medicare and Private Health Insurance Reimbursement Issues; Medicare Policies on Reimbursement for Powered Wheelchairs
CHAPTER 5: U.S. GOVERNMENT PROGRAMS AND LEGISLATION FOR THE ELDERLY: THE AMERICANS WITH DISABILITIES ACT; LITIGATION ON BEHALF OF THE ELDERLY; ADDITIONAL LEGISLATION; SAFETY AND QUALITY REGULATIONS; CLASS I AND II DEVICES; NUTRITION PROGRAMS; INFRASTRUCTURE CONSIDERATIONS
CHAPTER 6: INDUSTRY TRENDS BY SECTOR—HEALTHCARE: INDUSTRY TRENDS BY SECTOR—HEALTHCARE; ARTHRITIS; Current Treatments; Medications; • Rheumatoid Arthritis; • Anticytokine Agents; Nutritional Supplements; Future Arthritis Burden in the U.S; Market for Treatments for Arthritis for the Elderly; Opportunities for Growth Related to Arthritis; CARDIOVASCULAR DISEASES; Cardiovascular Disease in the U.S.; Cardiovascular Disease Internationally; Risk Factors; Treatments; Lifestyle Changes; Medications; Surgery; NEUROLOGICAL DYSFUNCTIONS; Related Dementias and Alzheimer’s Disease; Current Treatments for Alzheimer’s; DEPRESSION; Origins of the Disease; Genetic Factors; Biological Factors; Sociological Factors; Psychological Factors; Risk Factors for Depression; Gender; Age; Marital status; Family History; Social Support; Family Type; Medical Status; Types of Depression; Prevalence of the Disorder; Diagnosing Depression; Treatment for Depression; Therapy; Antidepressant Medications; • Market for Neurological Medications; CANCER; Types of Cancer; Costs for Cancer; Treatment for Seniors; DIABETES; Diabetes in the U.S; International Prevalence; Origins of the Disease; Type 2 Diabetes; Complications of Diabetes; Barriers to Care in the U.S.; Diagnosing Diabetes; Prediabetes; Treatment for Type 2 Diabetes; Prescription Trends in Diabetes Care; Medications for Type 2 Diabetes; The Elder Market for Diabetic Oral Agents; Types of Insulin; Long-acting Insulins; Rapid Insulins; Intermediate-acting Insulin; Short-acting Insulin; Blood Glucose Monitoring; Rationale for the Use of Blood Glucose Monitors; Nutrition and Exercise; COMMUNICATION DISORDERS; Speech Impairments; Writing Difficulties; Sensory Disabilities; Vision Loss; Eyeglass Market; Market for Vision Loss Products; Market for Eyewear Products for Seniors; Cataracts; Hearing Loss; Projected Senior Market for Hearing Aids; Cochlear Implants; Communication Aids; Speech Recognition; Vocal Output Technology; Developments in Communication Technology; Mobile Location Technology; Sensor Technology; Visual and Reading Aids; Newer adaptive technologies; MEMS-based Hearing Aids; Telephony Accessories; Vision and Reading Aids; Video Magnifiers; ORTHOPEDIC IMPAIRMENTS; Orthopedic Implant Market for Elders; Orthobiologic Market; Orthobiologics and Implications for Falls and the Elderly; RESPIRATORY CONDITIONS; Allergies and Asthma; ASTHMA; Origins of the Disease; Treatments; Costs for Asthma Medications; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD); Costs of COPD in the U.S,; Home Use of Oxygen and Respiratory Supplies; Costs of Respiratory Care; OTHER CHRONIC CONDITIONS; Dental Health; Osteoporosis; Age-related Loss of Strength/Balance/Coordination; UROLOGICAL PROBLEMS; Incontinence Medications; Benign Prostatic Hyperplasia (BPH); OBESITY
CHAPTER 7: INDUSTRY TRENDS BY SECTOR—HOUSING/PERSONAL CARE: OPTIONS FOR HOUSING; REMODELING TO REMAIN AT HOME; COSTS OF AT-HOME SENIOR SERVICES CARE; ADULT DAY CENTERS; ALTERNATIVE COMMUNITIES; Independent Living Communities; Recreationally Based Retirement Communities; Assisted Living; Costs for Assisted Living; Nursing Care; Paying for Skilled Nursing Services; Alzheimer’s Care; Costs of Alzheimer’s Care; UNPAID CAREGIVERS; PAID CAREGIVERS; Toll on Caregivers; LONG-TERM CARE; END-OF-LIFE CONSIDERATIONS; Legal Matters; Hospice and Alzheimer’s; Hospice Costs and Alzheimer’s Disease; MARKET OPPORTUNITIES IN ELDERCARE HOME SERVICES AND HOUSING OPTIONS; Market Opportunities in …(Continued)
CHAPTER EIGHT: INDUSTRY TRENDS BY SECTOR—ASSISTIVE TECHNOLOGY: HOME SAFETY PRODUCTS/SERVICES; ACTIVITY LOCATION/PERSONAL MONITORING AIDS; Activity/Emergency Location Monitors; Remote Medical Monitors; MARKET GROWTH; MARKET DRIVERS; Market Fragmentation; DAILY LIVING AIDS; The Market for Daily Living Aids; Market Share by Company; Incontinence Product Market; BATHING AIDS; Commode and Shower Chairs; MOBILITY AIDS; AMBULATORY AIDS; Ambulatory Aids Usage and Demographics; WHEELCHAIR/SCOOTER USE; Medicare Reimbursement for Powered Wheelchairs; MARKET SHARE LEADERS; MARKET DRIVERS; Special Purpose Wheelchairs; MOTOR VEHICLE CONVERSIONS; NAVIGATION AIDS; Ultrasound Guidance Systems; GPS Systems; ACCESS AIDS; MARKET FOR ACCESS AIDS; HOME ELEVATORS; WHEELCHAIR LIFTS; STAIR CLIMBERS; ACCESSIBLE BATHS AND SHOWERS; SPECIAL COMMODES; BATH AND POOL LIFTS; TRANSFER LIFTS; DOOR OPENERS; OTHER AIDS; Beds, Seating; Bariatric Beds; Seating and Positioning Systems; Ergonomic Aids; Computer Access Aids; Input Devices; Output Devices; Computer Software; ENVIRONMENTAL AIDS; ASSISTIVE TECHNOLOGIES UNDER DEVELOPMENT; ELECTRONICS; Mobile Location Technology; Sensor Technology; Artificial Intelligence; ENERGY SOURCES; MINIATURIZATION
CHAPTER NINE: COMPANY DIRECTORY: ABBOTT LABORATORIES; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; ASTRAZENECA PLC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; BAY ADVANCED TECHNOLOGIES, LTD.; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; BAYER AG (MILES-BAYER); BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; BRISTOL-MYERS SQUIBB; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; BROOKDALE SENIOR LIVING; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; CENTOCOR; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; COVIDIEN; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; ELI LILLY; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; FOREST PHARMACEUTICALS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; GENENTECH, INC.; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; GLAXOSMITHKLINE PLC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; GRAHAM-FIELD HEALTH PRODUCTS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; HONEYWELL HOMMED, LLC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; HUMANWARE; FINANCIALS; PRODUCTS; INVACARE CORP.; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; JOHNSON & JOHNSON; BUSINESS OVERVIEW; FINANCIAL INFORMATION; PRODUCTS; KIMBERLY CLARK; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; KINDRED HEALTHCARE; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; LIFE ALERT EMERGENCY RESPONSE; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; LIFE CARE CENTERS OF AMERICA; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; LIFE GUARDIAN LLC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; LIVHOME, INC.; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; HCR MANOR CARE; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; MAXHEALTH CORPORATON; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; MEDLINE INDUSTRIES, INC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; MERCK & CO INC; BUSINESS OVERVIEW; FINANCIAL INFORMATION; PRODUCTS; NOVARTIS AG; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; NOVO NORDISK; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; OPTELEC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; ORTHO-MCNEIL; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; PFIZER; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; PHILIPS LIFELINE SYSTEMS, INC.; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; PHONAK AG; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; PRIDE MOBILITY PRODUCTS CORP; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; ROCHE PHARMACEUTICALS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; SANOFI-AVENTIS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; SAVARIA CONCORD LIFTS, INC.; BUSINESS OVERIEW; FINANCIALS; PRODUCTS; SCA (SVENSKA CELLULOSA AKTIEBOLAGET); BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; SCHERING-PLOUGH; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; SIEMENS HEARING INSTRUMENTS, INC.; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; STARKEY LABORATORIES; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; SUNRISE MEDICAL, INC; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; SUNRISE SENIOR LIVING; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; TAKEDA PHARMACUETICALS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; THORNDIKE PRESS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; THYSSENKRUPP ACCESS; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; TYCO INTERNATIONAL; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; WIDEX; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; WYETH; BUSINESS OVERVIEW; FINANCIALS; PRODUCTS; APPENDIX; DEFINITIONS; ACTIVITIES OF DAILY LIVING (ADLS); ALZHEIMER’S DISEASE; ARTHRITIS; ASSISTIVE TECHNOLOGY; ASSISTED LIVING; BABY BOOMER; CAREGIVERS; CARDIOVASCULAR DISEASE (CVD); CONGESTIVE OBSTRUCTIVE PULMONARY DISEASE (COPD); DEMENTIA; DIABETES; DURABLE MEDICAL EQUIPMENT; ELDER/SENIOR; GERONTOLOGY; HOSPICE CARE; INSTRUMENTAL ACTIVITIES OF DAILY LIVING (IADL); LONG-TERM CARE; PROSTHETICS AND ORTHOTICS
LIST OF TABLES: SUMMARY TABLE PROJECTED NEEDS OF THE U.S. ELDERLY,; THROUGH 2014 ($ MILLIONS); TABLE 1 ESTIMATES FOR OVER-65 POPULATIONS BY U.S. REGION,; 2007; TABLE 2 MOST COMMON CHRONIC CONDITIONS BY AGE, GENDER,; AND RACE IN U.S., 2005; TABLE 3 COMPARISON OF ESTIMATED GOVERNMENT HEALTHCARE; SPENDING AS A PERCENT OF GDP, 2007 (%/$ MILLIONS)); TABLE 4 SELECTED PUBLIC AND PRIVATE PENSION; EXPENDITURES, 2006 ($ MILLIONS); TABLE 5 CURRENT MEDICARE/MEDICAID PAYMENTS FOR; SERVICES, 2009; TABLE 6 PROJECTED U.S. MARKET FOR ELDERCARE HEALTHCARE; PRODUCTS AND SERVICES, THROUGH 2014 ($ MILLIONS); TABLE 7 INCIDENCE OF DIAGNOSED ARTHRITIS CASES AND; CHRONIC JOINT SYMPTOMS IN THE U.S. BY AGE GROUP, 2006; (MILLION PERSONS); TABLE 8 NEWER ANTICYTOKINE AGENTS FOR THE TREATMENT OF; RHEUMATOID ARTHRITIS; TABLE 9 PROJECTED U.S. MARKET FOR PHARMACEUTICAL; ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, AT; MANUFACTURER’S COST, THROUGH 2014 ($ MILLIONS); TABLE 10 SELECTED HEART DISEASE MEDICATIONS; TABLE 11 GLOBAL MARKET FOR CARDIOVASCULAR DISEASE; MEDICATIONS, THROUGH 2014 ($ MILLIONS); TABLE 12 U.S. MARKET FOR CARDIOVASCULAR DISEASE; MEDICATIONS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS); TABLE 13 U.S. MARKET FOR CARDIOVASCULAR SURGICAL; PROCEDURES FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS); TABLE 14 COMMON PRESCRIPTION MEDICATIONS TO TREAT; ALZHEIMER’S DISEASE; TABLE 15 PERCENTAGE OF PATIENTS WHO REPORT BEING; DEPRESSED, BY CHRONIC CONDITION (%); TABLE 16 GLOBAL DIRECT AND INDIRECT COST OF DEPRESSION,; THROUGH 2014 ($ MILLIONS); TABLE 17 SELECTED ANTIDEPRESSANT MEDICATIONS; TABLE 18 PROJECTED U.S. MARKET FOR DEMENTIA AND; DEPRESSION MEDICATIONS FOR THE ELDERLY, THROUGH 2014; ($ MILLIONS); TABLE 19 PROJECTED GLOBAL COSTS FOR CANCER TREATMENTS,; THROUGH 2014 ($ MILLIONS); TABLE 20 PROJECTED U.S. MARKET FOR ALL TYPES OF CANCER; TREATMENTS FOR INDIVIDUALS OVER 65, THROUGH 2014; ($MILLIONS); TABLE 21 SELECTED DIABETIC ORAL AGENTS, BY TYPE, TRADE; NAME AND MANUFACTURER; TABLE 22 GLOBAL MARKET FOR DIABETIC ORAL AGENTS,; THROUGH 2014 ($ MILLIONS); TABLE 23 U.S. MARKET FOR DIABETIC ORAL AGENTS FOR ADULTS; OLDER THAN 65, THROUGH 2014 ($ MILLIONS); TABLE 24 INSULIN MARKET IN U.S. FOR INDIVIDUALS OVER 65,; THROUGH 2014 ($ MILLIONS); TABLE 25 SELECTED LIST OF COMPANIES MARKETING GLUCOSE; MONITORING TESTS; TABLE 26 GLOBAL MARKET FOR BLOOD GLUCOSE MONITORING; DEVICES, THROUGH 2014 ($ MILLIONS); TABLE 27 U.S. BLOOD GLUCOSE MONITORING MARKET THROUGH; 2014 ($ MILLIONS); TABLE 28 GLOBAL BLOOD GLUCOSE MONITORING MARKET FOR; INDIVIDUALS OLDER THAN 65, THROUGH 2014 ($ MILLIONS); TABLE 29 U.S. BLOOD GLUCOSE MONITORING MARKET FOR; INDIVIDUALS OLDER THAN 65, THROUGH 2014 ($ MILLIONS); TABLE 30 PREVALENCE OF AGE-RELATED EYE DISEASES, 2004 (%); TABLE 31 PROJECTED U.S. EYEWEAR SALES, THROUGH 2014 ($; MILLIONS); TABLE 32 PROJECTED U.S. EYEWEAR SALES FOR INDIVIDUALS; OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 33 PROJECTED COST OF CATARACT SURGERY FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 34 SELECTED HEARING AID MANUFACTURERS; TABLE 35 REPORTED INCIDENCE OF HEARING PROBLEMS AMONG; U.S. ADULTS BY SEX/AGE GROUP, 2006 (%); TABLE 36 PROJECTED U.S. MARKET FOR HEARING AIDS FOR; INDIVIDUALS OVER 65, AT RETAIL PRICING, THROUGH 2014 ($MILLIONS)*; TABLE 37 2007 VISION AND READING AIDS SALES; TABLE 38 PROJECTED TRENDS IN NUMBER OF U.S. TOTAL HIP AND; KNEE REPLACEMENTS, THROUGH 2014 (THOUSANDS OF; PROCEDURES); TABLE 39 U.S. ORTHOPEDIC IMPLANT MARKET BY NUMBER AND; TYPE OF PROCEDURE, THROUGH 2014; TABLE 40 PROJECTED U.S. AND REST OF THE WORLD ORTHOPEDIC; IMPLANT MARKET GROWTH, THROUGH 2014 ($ MILLIONS); TABLE 41 PROJECTED U.S. COSTS OF ORTHOPEDIC SURGERY FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 42 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 43 SELECTED LIST OF COMMON ALLERGY/ASTHMA; MEDICATIONS; TABLE 44 SELECTED LISTING OF INHALED CORTICOSTEROIDS; TABLE 45 GLOBAL COSTS FOR ASTHMA MEDICATIONS FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 46 U.S. COSTS FOR ASTHMA MEDICATIONS FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 47 PROJECTED COSTS OF HOME OXYGEN AND RESPIRATORY; SUPPLIES FOR INDIVIDUALS OVER 65, THROUGH 2014 ($; MILLIONS); TABLE 48 PROJECTED MARKET FOR INCONTINENCE MEDICATIONS; FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 49 SELECTED MEDICATIONS FOR BPH; TABLE 50 PROJECTED U.S. MARKET FOR BPH MEDICATIONS FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 51 GLOBAL MARKET FOR PRESCRIPTION WEIGHT LOSS; PRODUCTS THROUGH 2014 ($ MILLIONS); TABLE 52 PROJECTED HOUSING MARKETS FOR SENIORS OVER 65,; THROUGH 2014 ($ MILLIONS); TABLE 53 PROJECTED SPENDING ON HOME RENOVATION; PROJECTS BY INDIVIDUALS OVER 65, THROUGH 2014 ($; MILLIONS); TABLE 54 AVERAGE ANNUAL COST OF HOME CARE SERVICES, 2008; ($); TABLE 55 PROJECTED MARKET FOR HOME CARE SERVICES,; THROUGH 2014 ($ MILLIONS); TABLE 56 PROJECTED GROWTH OF ASSISTED-LIVING COSTS IN THE; U.S. FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 57 PROJECTED MARKET FOR SKILLED NURSING FACILITIES; FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 58 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES FOR; THE ELDERCARE MARKET, THROUGH 2014 ($ MILLIONS); TABLE 59 SELECTED MEDICAL/PERSONAL MONITORING AID; MANUFACTURERS; TABLE 60 PROJECTED U.S. SALES OF MEDICAL/PERSONAL; MONITORING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($; MILLIONS); TABLE 61 SELECTED DAILY LIVING AIDS MANUFACTURERS; TABLE 62 PROJECTED U.S. SALES OF DAILY LIVING AIDS FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 63 DAILY LIVING AIDS MANUFACTURERS, SALES AND; PERCENT OF MARKET, 2007 ($ MILLIONS/PERCENT); TABLE 64 PROJECTED U.S. SALES OF INCONTINENCE AND OSTOMY; PRODUCTS, THROUGH 2014 ($ MILLIONS); TABLE 65 PROJECTED U.S. SALES OF COMMODE AND SHOWER; CHAIRS TO INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 66 REPORTED INCIDENCE OF IMPAIRED MOBLITY AND; DEXTERITY IN THE U.S. BY SEX/AGE GROUP, 2006 (%); TABLE 67 PROJECTED U.S. MARKET FOR MOBILITY PRODUCTS FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 68 SELECTED AMBULATORY AID MANUFACTURERS; TABLE 69 PROJECTED U.S. SALES OF AMBULATORY AIDS FOR; INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS); TABLE 70 SELECTED LIST OF WHEELCHAIR AND SCOOTER; MANUFACTURERS; TABLE 71 WHEELCHAIR TYPES AND PERCENT OF MARKET, 2007 (%); TABLE 72 PROJECTED U.S, MARKET FOR WHEELCHAIR/SCOOTER; MOBILITY PRODUCTS FOR THE ELDERLY, THROUGH 2014 ($; MILLIONS); TABLE 73 SELECTED NAVIGATION AIDS MANUFACTURERS; TABLE 74 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS BY; SEGMENT, THROUGH 2014 ($ MILLIONS); TABLE 75 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS FOR; INDIVIDUALS OVER 65, BY SEGMENT, THROUGH 2014 ($; MILLIONS); TABLE 76 SELECTED ACCESS AID MANUFACTURERS; TABLE 77 SELECTED MANUFACTURERS OF BED, SEATING, AND; ERGONOMIC AIDS FOR THE ELDERLY; TABLE 78 PROJECTED MARKET FOR BEDS, SEATING SYSTEMS, AND; ERGONOMIC AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($; MILLIONS); TABLE 79 EXAMPLES HAVE ERGONOMIC AIDS FOR THE ELDERLY; TABLE 80 SELECTED COMPUTER AID MANUFACTURERS; TABLE 81 SELECTED ENVIRONMENTAL AID MANUFACTURERS
LIST OF FIGURES: SUMMARY FIGURE PROJECTED NEEDS OF THE U.S. ELDERLY, BY; MARKET SEGMENT, 2008-2014 ($ MILLIONS); FIGURE 1 DISTRIBUTION OF OVER-65 U.S POPULATION BY; RACE/ETHNICITY 2007 AND 2015 (%); FIGURE 2 PREVALANCE OF CHRONIC CONDITIONS AMONG ADULTS; IN THE U.S. OVER 65 YEARS OF AGE, BY RACE AND ETHNICITY (%); FIGURE 3 CHRONIC CONDITIONS IN U.S. POPULATION OVER 65,; 2005 (%); FIGURE 4 U.S. NATIONAL SPENDING ON LONG-TERM CARE, BY; PAYER, 2005 (%); FIGURE 5 LEADING CAUSES OF U.S. DEATHS IN THOSE OVER 65,; 2007 (%); FIGURE 6 PROJECTED U.S. POPULATION OVER 65 BY 2050 (%); FIGURE 7 RECIPIENTS OF SOCIAL SECURITY BENEFITS, 2006 (%); FIGURE 8 FUTURE BURDEN OF ARTHRITIS FOR THOSE OVER 65 IN; THE U.S., BY GENDER, 2010-2030 (MILLIONS); FIGURE 9 CAUSES OF DEMENTIA IN PEOPLE OVER 65 (%); FIGURE 10 ESTIMATED NEW CASES OF CANCER IN THE U.S., 2008; (%); FIGURE 11 U.S. MARKET FOR EYEGLASSES AND CONTACTS IN 2007; (%); FIGURE 12 PROJECTED LIFETIME LONG-TERM CARE NEEDS FOR; INDIVIDUALS OVER 65 (%); FIGURE 13 DAILY LIVING MARKET, BY SEGMENT AND TOTAL; PERCENT OF SALES, 2007 (%); FIGURE 14 PERCENT OF TOTAL SALES FOR OTHER DAILY LIVING; AIDS, 2007 (%)

More United States Diseases & Conditions Reports

Insulin - Top 5 American Markets by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 American markets. ...

Insulin - Americas by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in American markets. The analyses ...

Insulin - United States by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in United States. The study provides essential ...

Calming and Sleeping in the US by Euromonitor International
In January 2010, McNeil recalled nine lots of its leading brand Simply Sleep. In the following years, consumers reported that the brand had totally vanished ...

The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers by Venture Planning Group
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

The Elder Care Market: Products and Services

Share this report

Other tasks

Research Assistance

Related Markets

Diseases & Conditions Reports

Free Alert Me service